A trial of D-Ribose supplementation is recruiting individuals who are experiencing fatigue associated with a diagnosis of fibromyalgia. The trial (“D-Ribose for Fatigue in Subjects with Fibromyalgia”) is directed by Leslie J Crofford, MD, a specialist in fibromyalgia and autoimmune diseases at the University of Kentucky. It is recruiting at Dr. Crofford’s clinic and at 7 other sites in California, Florida, Maryland, and North Carolina.
This 12-week trial involving daily supplementation with D-Ribose is “a phase IIa, randomized, double-blind, placebo-controlled, multi-center, multiple dose study of the dietary supplement D-ribose vs placebo.”
Subscribe to the World's Most Popular Newsletter (it's free!)
See the ClinicalTrials.gov listing of this trial for more information on inclusion and exclusion criteria, locations, and links to clinic contacts at www.clinicaltrials.gov/ct2/show/NCT01315210
For background information about ribose, see “Ribose: A major component of the ‘energy molecule’ ATP,” by nutritient scientist Brian Tanzer, MS, CNS, Sep 14, 2011